Fuze Health

What Fuze Health does

Fuze Health is a private healthcare technology company formed in 2025 through the combination of Truepill, LetsGetChecked, and Alto Pharmacy, operating from a Delaware-incorporated holding entity (Fuze Corporate Inc.) with principal operations in Fairfield, Ohio, and pharmacy hubs in Hayward, California and Sharonville, Ohio. The company sells to four enterprise buyer types — health systems, employers, health plans, and life sciences firms — and reaches consumers directly through its fertility and specialty pharmacy portal. Its three branded business units are FuzeRx (digital pharmacy), Fuze Services (clinical and genomic programs), and Fuze Technologies (proprietary software and consulting).

The platform centers on FuzeRx, a RESTful JSON API with key-based authentication, sandbox and production environments, and TLS 1.2/HIPAA-compliant cloud infrastructure that supports prescription management, transfers, fill requests, prior authorization, coverage checks, telehealth consults, insurance billing, and an asynchronous webhook event system (NOTIFY_RX, ORDER, SHIPMENT, TRANSFER, DIRECT_TRANSFER, COPAY, COVERAGE, PRIOR_AUTH, CONSULT). It is accredited by URAC as a Mail Service and Specialty Pharmacy (through April 2029) and licensed across all 50 US states. The Veritas Genetics subsidiary extends the stack into whole-genome sequencing, and subsidiary brands (Truepill, LetsGetChecked, Alto Pharmacy, PatientsLikeMe) extend reach into telehealth, at-home diagnostics, women's health, and patient community data. Disclosed scale metrics are 22M patients served, 31M prescriptions delivered, 90% payer coverage, and 7M+ clinical interactions.

Revenue is generated through three streams: (i) transaction-based prescription fulfillment fees (specialty pharmacy, fertility medications, same-day and next-day delivery across all 50 states); (ii) recurring/subscription API platform services to partners embedding pharmacy infrastructure programmatically via the FuzeRx API and Stripe-mediated payment intents; and (iii) managed clinical services spanning diagnostics, screening, preventive genomics, telehealth, and prior authorization support. Distribution combines API-first partner integration, embedded/white-label fulfillment (illustrated by Genentech's Direct-to-Patient Xofluza program via Alto Pharmacy, with a $50 cash-pay option), enterprise field sales targeting health systems and payers, and a direct-to-consumer patient portal with 24/7 pharmacist access. Pricing is largely quote-based for enterprise contracts; the Genentech Xofluza DTP program offers a $50 cash-pay reference price point.

Name

Fuze Health

Legal name

Fuze Corporate Inc.

Website

https://fuzehealth.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Fuze Health, formed in 2025 from Truepill, LetsGetChecked, and Alto Pharmacy, operates an API-powered digital pharmacy and clinical services platform serving health systems, employers, health plans, life sciences firms, and specialty patients through FuzeRx, Fuze Services, and Fuze Technologies brands.

Ownership category

akta.pro rank

Product category

Digital Pharmacy Services

NAICS

Pharmacies and Drug Retailers (456110), Pharmacies and Drug Retailers (45611), Couriers and Express Delivery Services (492110)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Pharmacy Fulfillment & Mail-Order Enablement for Telehealth (dispensing, shipping, tracking) (HLALAIAE)

akta.pro secondary industries

Specialty Pharmacy–Integrated Telehealth (biologics, complex therapies, REMS) (HLALAIAF), Pharmacy & Health Essentials Delivery (CRAFAFAI), Health & Pharmacy Omnichannel (CRAFAEAK)

Keywords

• Digital pharmacy services
• Prescription fulfillment
• Specialty pharmacy
• Healthcare API platform
• Clinical genomics

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmacy Fulfillment Services: Digital pharmacy prescription fulfillment across all 50 states with same-day and next-day delivery options. Revenue generated from prescription dispensing, including specialty pharmacy and fertility medications.
2. API Platform Services: Programmable pharmacy infrastructure enabling partners to integrate prescription management, patient records, and fulfillment into their own platforms via API.
3. Clinical Services: Integrated diagnostic, screening, genomic, and clinical programs including preventive genomics, telehealth consultations, and prior authorization support.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels3 records

Core offering

Fuze Health operates a technology-driven digital pharmacy and clinical services platform that combines prescription fulfillment across all 50 US states with integrated diagnostic, screening, genomic, and clinical programs. The company dispenses medications through URAC-accredited mail service and specialty pharmacies, delivers via same-day and next-day shipping, and exposes its pharmacy infrastructure via the FuzeRx RESTful JSON API for partner integration.

Product overview

Fuze Health is a next-generation healthcare technology platform formed from the combination of Truepill, LetsGetChecked, and Alto Pharmacy. The company operates as a unified digital health platform connecting testing, treatment, and wellness through three core offerings: FuzeRx (digital pharmacy solutions with API-powered prescription fulfillment), Fuze Services (clinical services including diagnostic, screening, and genomic programs), and Fuze Technologies (proprietary clinical and analytical software). The platform serves health systems, employers, health plans, and life sciences companies, providing pharmacy fulfillment across all 50 states, telehealth capabilities, patient engagement tools, and integrated clinical pathways. Notable sub-brands include FuzeRx Fertility Pharmacy (specialized fertility medication delivery) and Veritas Genetics (preventive genomics through whole-genome sequencing).

Differentiator

Problem solved

Functional benefit

Brands

• FuzeRx: Next-generation digital pharmacy solutions offering API-powered prescription fulfillment, 24/7 multi-model support, and advanced patient engagement tools.
• Fuze Services
• Fuze Technologies

Products and services

• FuzeRx Next-generation digital pharmacy solution providing API-powered prescription fulfillment across all 50 US states, 24/7 multi-model patient support, same-day and next-day medication delivery, and advanced patient engagement tools. Serves health systems, health plans, employers, life sciences, and direct patients.
• Fuze Services Proactive and predictive clinical services driving early intervention, risk identification, and precision medicine through integrated diagnostic, screening, genomic, telehealth, and clinical programs for healthcare partners and patients.
• Fuze Technologies Proprietary clinical, analytical, and community software, plus expert consulting services for advancing partner-owned healthcare platforms. Delivers better experiences and outcomes through emerging technology offerings.
• FuzeRx Fertility Pharmacy Specialized fertility pharmacy service offering 24/7 access to fertility-trained pharmacists, free next-day nationwide delivery of fertility medications, and integration with fertility benefit insurance plans. Targeted at fertility patients transitioning from Optum Specialty Pharmacy.
• Veritas Genetics Preventive Genomics Whole-genome sequencing program with actionable genomic insights, integrated care pathways including confirmatory testing, specialist referrals, and genetic counseling, offered through a consortium with Illumina for US and global markets.

Quantifiable outcome

• 22M patients served
• +3 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• IlluminacoreStrategic or Co-development Partner · 16 March 2026Preventive genomics consortium partnership between Illumina and Veritas Genetics (part of Fuze Health) to launch an opt-in preventive genomics program in the US and global markets. Provides whole-genome sequencing with actionable genomic insights, integrated care pathways including confirmatory testing, specialist referrals, and genetic counseling. Aims to generate a consented clinical-genomics dataset leveraging Illumina's sequencing capabilities with Veritas's patient-ready reporting.
• Alto Pharmacy (Genentech Collaboration)minorChannel Partner/ Reseller/ Distributor · 16 October 2025Alto Pharmacy participates in Genentech's Direct-to-Patient Xofluza program, offering $50 cash pay option and same-day home delivery for eligible flu patients in select U.S. markets.
• Alto PharmacycoreStrategic or Co-development Partner · 1 May 2025Strategic acquisition in May 2025 to expand pharmacy services with same-day medication delivery and specialized women's health offerings. Alto Pharmacy now operates as part of Fuze Health's platform.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Capsule: Capsule is a digital-first pharmacy offering same-day prescription delivery and a patient-facing app in major US metros. It competes directly with FuzeRx in consumer-facing mail-order and specialty fulfillment and operates a similar B2B2C model.
• Mark Cuban Cost Plus Drugs: Cost Plus Drug Company is a transparent-pricing mail-order pharmacy competing in the same prescription fulfillment space as FuzeRx, particularly for cash-pay and generic-heavy scripts, and expanding into specialty categories that overlap with Alto.
• Ro: Ro operates a vertically integrated telehealth and pharmacy platform spanning men's health, women's health, and primary care. Its pharmacy infrastructure and API-enabled partner integrations overlap directly with FuzeRx's prescription fulfillment and clinical services offerings.
• Hims & Hers Health: Hims & Hers combines telehealth consultations with direct-to-patient pharmacy fulfillment across specialty and wellness categories. It mirrors Fuze Health's integrated consult-plus-dispensing model and competes for the same consumer and employer-channel customers.

Broad incumbents

• CVS Caremark: CVS Caremark is one of the largest US pharmacy benefit managers and mail-order pharmacy operators. As a broad incumbent, it overlaps with Fuze Health's specialty and mail-service pharmacy offerings, and its Caremark network defines payer relationships Fuze must integrate with.
• Amazon Pharmacy: Amazon Pharmacy (built on PillPack) is the largest scaled digital pharmacy in the US, offering home delivery, insurance integration, and Prime-linked fulfillment. It competes with FuzeRx on speed, scale, and B2C customer acquisition, though its API partner program is less mature.
• OptumRx: OptumRx is UnitedHealth Group's mail-order and specialty pharmacy arm and one of the largest pharmacy benefit managers in the US. It is both a counterparty (Optum transitioned fertility patients to Fuze) and a competitor in specialty pharmacy fulfillment and integrated payer services.
• Walgreens (VillageMD): Walgreens operates one of the largest US retail and mail-order pharmacy networks and, through VillageMD, an integrated primary care platform. Its scale in 50-state dispensing and growing digital efforts make it a broad incumbent competitor to FuzeRx's omnichannel pharmacy.

Emerging players

• DiRx: DiRx is an online pharmacy offering generic medications at transparent cash-pay prices, similar to Cost Plus Drugs. It competes with FuzeRx in the mail-order pharmacy space, particularly for uninsured or high-deductible patients seeking affordable generic fulfillment.
• Medly Pharmacy: Medly is a digital pharmacy offering same-day delivery and patient management tools in select US markets. It overlaps with FuzeRx in D2C mail-order and is a smaller-scale but comparable emerging competitor in the digital pharmacy category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/fuze-health-inc

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fuze Health